DK600486A - Igg-bindingsprotein - Google Patents

Igg-bindingsprotein

Info

Publication number
DK600486A
DK600486A DK600486A DK600486A DK600486A DK 600486 A DK600486 A DK 600486A DK 600486 A DK600486 A DK 600486A DK 600486 A DK600486 A DK 600486A DK 600486 A DK600486 A DK 600486A
Authority
DK
Denmark
Prior art keywords
recombinant dna
sequence
fragment
dna molecule
molecule
Prior art date
Application number
DK600486A
Other languages
Danish (da)
English (en)
Other versions
DK600486D0 (da
Inventor
Lars Abrahmsen
Tomas Moks
Bjoern Nilsson
Mathias Uhlen
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Publication of DK600486D0 publication Critical patent/DK600486D0/da
Publication of DK600486A publication Critical patent/DK600486A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK600486A 1985-12-13 1986-12-12 Igg-bindingsprotein DK600486A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505922A SE8505922D0 (sv) 1985-12-13 1985-12-13 Construction of an igg binding protein to facilitate downstream processing using protein engineering

Publications (2)

Publication Number Publication Date
DK600486D0 DK600486D0 (da) 1986-12-12
DK600486A true DK600486A (da) 1987-06-14

Family

ID=20362468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK600486A DK600486A (da) 1985-12-13 1986-12-12 Igg-bindingsprotein

Country Status (11)

Country Link
US (1) US5143844A (fr)
EP (1) EP0230869B1 (fr)
JP (1) JPH0811069B2 (fr)
AT (1) ATE80180T1 (fr)
AU (1) AU600244B2 (fr)
CA (1) CA1311430C (fr)
DE (1) DE3686646T2 (fr)
DK (1) DK600486A (fr)
ES (1) ES2046177T3 (fr)
GR (1) GR3006178T3 (fr)
SE (1) SE8505922D0 (fr)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
SE8505921D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab A method to export gene products to the growth medium of gram negative bacteria
SE8601940D0 (sv) * 1986-04-25 1986-04-25 Kabigen Ab Preparation of fused proteins, antibodies and processes therefor
US5985599A (en) * 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
ATE243754T1 (de) * 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
WO1988009343A1 (fr) * 1987-05-29 1988-12-01 Sagami Chemical Research Center Proteine fusionnee contenant une lymphotoxine
US5243040A (en) * 1987-11-20 1993-09-07 Creative Biomolecules DNA encoding a protein which enables selective removal of immune complexes
US5084398A (en) * 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
AU623361B2 (en) * 1987-11-20 1992-05-14 Creative Biomolecules, Inc. Selective removal of immune complexes
SE8800981D0 (sv) * 1988-03-17 1988-03-17 Nygren Per Ake A recombinant fusion protein, its use and a recombinant vector
SE509359C2 (sv) * 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
GB8927008D0 (en) * 1989-11-29 1990-01-17 Ciba Geigy Novel process for the production of unfused protein in e.coli
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US6077694A (en) * 1990-09-21 2000-06-20 The United States Of America As Represented By The Department Of Health And Human Services Method for over-expression and rapid purification of biosynthetic proteins
US5863783A (en) * 1991-03-27 1999-01-26 Gist-Brocades, N.V. Cloning and expression of DNA molecules encoding arabinan-degrading enzymes of fungal origin
AU2368892A (en) * 1991-07-29 1993-03-02 British Bio-Technology Limited Igf-ii analogues
US5989887A (en) * 1992-11-25 1999-11-23 Dsm N.V. Cloning and expression of DNA molecules incoding arabinan-degrading enzymes of fungal origin
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
US5917026A (en) * 1996-02-05 1999-06-29 Loewenadler; Bjoern Fusion proteins of immunopotentiating activity
US5962270A (en) * 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
WO1998011913A1 (fr) * 1996-09-16 1998-03-26 Dalhousie University Utilisation de l'igf-i pour le traitement des polykistoses renales et des troubles associes
US6593290B1 (en) 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US6156728A (en) 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
IL143834A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
DE60016560T2 (de) 1999-01-06 2005-12-15 Genentech, Inc., South San Francisco Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i)
DK1165119T3 (da) 1999-04-08 2003-12-15 Genentech Inc Sammensætning baseret på modsat ladede polypeptider
DE60133271T2 (de) 2000-05-16 2009-04-23 Genentech, Inc., South San Francisco Behandlung von knorpelerkrankungen
US20030157561A1 (en) * 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
US20050003548A1 (en) * 2002-07-22 2005-01-06 Nikolay Korokhov Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof
ATE536186T1 (de) 2003-09-12 2011-12-15 Tercica Inc Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel
CA2541015A1 (fr) * 2003-10-03 2005-04-14 Genentech, Inc. Proteines de liaison a l'igf
EP1732613A2 (fr) 2004-04-06 2006-12-20 Affibody AB Utilisation de conjugues comprenant un peptide capable de lier l'albumine serique pour la preparation de medicament
EP2465870A1 (fr) 2005-11-07 2012-06-20 Genentech, Inc. Polypeptides de liaison dotés de séquences hypvervariables VH/VL diversifiées et consensuelles
RU2470941C2 (ru) 2005-12-02 2012-12-27 Дженентек, Инк. Связывающие полипептиды и их применения
JP2008048607A (ja) 2006-08-22 2008-03-06 Chisso Corp Ｆｃ結合ドメインとカルシウム結合発光蛋白質との融合蛋白質、それをコードする遺伝子およびそれらの用途
GB2442118B (en) * 2006-09-19 2011-08-17 Chisso Corp Process for production of recombinant proteins as a soluble form
WO2008127457A2 (fr) 2006-12-06 2008-10-23 Repligen Corporation Acides nucléiques codant pour la protéine recombinée a
US8198043B2 (en) * 2006-12-08 2012-06-12 General Electric Company Two helix binders
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
US9403883B2 (en) 2009-03-24 2016-08-02 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
JP5501439B2 (ja) 2009-04-02 2014-05-21 ロシュ グリクアート アクチェンゲゼルシャフト 完全長抗体と単鎖Ｆａｂフラグメントとを含む多重特異的抗体
SG10201408401RA (en) 2009-09-16 2015-01-29 Genentech Inc Coiled coil and/or tether containing protein complexes and uses thereof
JP5951509B2 (ja) * 2010-03-08 2016-07-13 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 免疫グロブリンＧＦｃ領域結合ポリペプチド
CN107188936B (zh) 2010-03-24 2021-08-10 株式会社钟化 特异性结合免疫球蛋白的蛋白质以及免疫球蛋白结合性亲和配体
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
MX346731B (es) 2010-04-23 2017-03-30 Genentech Inc * Producción de proteínas heteromultiméricas.
MX2013001267A (es) 2010-08-13 2013-04-10 Genentech Inc ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD.
WO2012025530A1 (fr) 2010-08-24 2012-03-01 F. Hoffmann-La Roche Ag Anticorps bispécifiques comprenant un fragment fv stabilisé par bisulfure
CN103269762B (zh) 2010-12-20 2016-01-27 通用电气健康护理生物科学股份公司 亲和色谱基质
EP2654915B1 (fr) 2010-12-20 2018-10-24 GE Healthcare BioProcess R&D AB Matrice de chromatographie par affinité
EP2655413B1 (fr) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Complexe polypeptide-polynucléotide et son utilisation dans l'administration d'une fraction effectrice ciblée
AR085138A1 (es) 2011-02-04 2013-09-11 Genentech Inc VARIANTES DE Fc Y METODOS PARA SU PRODUCCION
US10689447B2 (en) 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
KR20140007394A (ko) * 2011-03-25 2014-01-17 가부시키가이샤 가네카 면역 글로불린 결합성 신규 폴리펩티드
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
KR102492792B1 (ko) 2011-10-11 2023-01-30 제넨테크, 인크. 이중특이적 항체의 개선된 어셈블리
CN104105711B (zh) 2012-02-10 2018-11-30 弗·哈夫曼-拉罗切有限公司 单链抗体及其他异多聚体
WO2013147691A1 (fr) 2012-03-28 2013-10-03 Ge Healthcare Bio-Sciences Ab Matrice de chromatographie par affinité
MX2014014804A (es) 2012-06-27 2015-02-12 Hoffmann La Roche Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo.
HK1207864A1 (zh) 2012-06-27 2016-02-12 F. Hoffmann-La Roche Ag 用於选择并产生含有至少两种不同结合实体的定制高度选择性和多特异性靶向实体的方法及其用途
EP3019520B1 (fr) 2013-07-10 2019-12-11 GE Healthcare BioProcess R&D AB Polypeptides de liaison à une immunoglobuline mutante
JP6491600B2 (ja) 2013-09-27 2019-03-27 株式会社カネカ アルカリ水溶液を用いた多孔質セルロースビーズの製造方法
BR112016024462B1 (pt) 2014-05-06 2022-12-27 Genentech, Inc Métodos para a preparação de um anticorpo
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
ES2764111T3 (es) 2014-12-03 2020-06-02 Hoffmann La Roche Anticuerpos multiespecíficos
WO2016121701A1 (fr) 2015-01-26 2016-08-04 株式会社カネカ Matrice pour séparation par affinité destinée à la purification de protéines contenant la région variable de la chaîne kappa des immunoglobulines
CN108064286A (zh) 2015-01-26 2018-05-22 株式会社钟化 突变型免疫球蛋白κ链可变区结合性肽
JP6424101B2 (ja) * 2015-01-30 2018-11-14 Jnc株式会社 Ｆｃ結合ドメインとカルシウム結合発光蛋白質との融合蛋白質、それをコードする遺伝子およびそれらの用途
EP3255058B1 (fr) 2015-02-05 2021-03-24 Mitsubishi Chemical Corporation Protéine présentant une affinité pour l'immunoglobuline et milieu de séparation par affinité et colonne pour chromatographie en phase liquide l'utilisant
WO2017195638A1 (fr) 2016-05-09 2017-11-16 株式会社カネカ Procédé de purification d'un anticorps ou d'un fragment d'anticorps comportant une région variable de chaîne κ
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
ES2874974T3 (es) 2016-05-11 2021-11-05 Cytiva Bioprocess R & D Ab Matriz de separación
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CA3072288A1 (fr) 2017-08-07 2019-02-14 Repligen Corporation Proteines de liaison fc avec la cysteine dans la region helicoidale c-terminale
EP3521304B9 (fr) 2018-02-01 2023-10-04 Repligen Corporation Protéines de liaison fc avec la cystéine dans la région hélicoïdale c-terminale
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
WO2026057420A1 (fr) 2024-09-10 2026-03-19 Cytiva Bioprocess R&D Ab Ligand d'affinité pour la purification d'anticorps d'isotype iga

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta

Also Published As

Publication number Publication date
AU6633186A (en) 1987-06-18
ES2046177T3 (es) 1994-02-01
JPS62190087A (ja) 1987-08-20
EP0230869B1 (fr) 1992-09-02
AU600244B2 (en) 1990-08-09
CA1311430C (fr) 1992-12-15
EP0230869A3 (en) 1988-08-03
JPH0811069B2 (ja) 1996-02-07
DK600486D0 (da) 1986-12-12
EP0230869A2 (fr) 1987-08-05
DE3686646D1 (de) 1992-10-08
ATE80180T1 (de) 1992-09-15
GR3006178T3 (fr) 1993-06-21
DE3686646T2 (de) 1993-04-08
SE8505922D0 (sv) 1985-12-13
US5143844A (en) 1992-09-01

Similar Documents

Publication Publication Date Title
DK600486D0 (da) Igg-bindingsprotein
Kodaira et al. The dnaX gene encodes the DNA polymerase III holoenzyme τ subunit, precursor of the γ subunit, the dnaZ gene product
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
JPS57181099A (en) Bacillus cloning vector, recombinant dna molecule, bacillus host transformed thereby and manufacture of polypeptide expressing dna order and being coded thereby
IL57491A (en) Recombinant dna,methods for the production thereof and proteins or polypeptides produced thereby
AU2705895A (en) Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
DK38189A (da) Hidtil ukendte fusionsproteiner indeholdende glutation-s-transferase
ATE184052T1 (de) Gdf-1 und uog1 proteine
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
PT737747E (pt) Expressao citoplasmatica na e. coli de anticorpos fragmentos de anticorpos e moleculas de fusao de fragmentos de anticorpos
Johnson et al. Identification of a plastid-specific ribosomal protein in the 30 S subunit of chloroplast ribosomes and isolation of the cDNA clone encoding its cytoplasmic precursor.
JPS6420095A (en) Polypeptide having anti-blood coagulating action
HUT52551A (en) Process for production of neutrophil-activizating factor
Miele et al. Gene organization and nucleotide sequence of the primase region of IncP plasmids RP4 and R751
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
Roberts et al. Different active sites of mammalian DNA ligases I and II.
Sarvas et al. A precursor form of the penicillinase from Bacillus licheniformis
DE3572843D1 (en) Site-specific proteolysis by renin
EP0159943A3 (en) Expression vectors, dna fragments, peptides, hosts, and process for production of proteins
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
Taylor et al. Similarities in the heavy and light chains of tetanus toxin suggested by their amino acid compositions
DK551786A (da) Rekombinant-dna-sekvens, der koder for aminosyresekvenser i et toksin, expressionssystem omfattende samme og vaertsceller transformeret hermed
WO1998025957A3 (fr) GENES DE LA PROTEINE HUMAINE A SOUS-UNITE DE TYPE Prt1 (hPrt1) ET DE LA PROTEINE HUMAINE DU TYPE eIF4G (p97)
ES2152976T3 (es) Proteina crp mutante, procedimientos y medios para su fabricacion y su utilizacion.
TW287199B (en) A method for genetically producing a protein exhibiting the activity of epstein-barr virus DNA polymerase

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment